2024-05-15T10:54:28-05:00 2023-06-30 133628255 CONDON O'MEARA MCGINTY & DONNELLY LLP ONE BATTERY PARK PLAZA 7TH FL NEW YORK NY 10004 990 2022-07-01 202905531 NEW YORK STEM CELL FOUNDATION INC NEWY 2123657428 619 WEST 54TH STREET 3RD FL NEW YORK NY 10019 JEFFREY WALLERSTEIN CFO & COO 2123657428 2024-05-14 1 JEFFREY WALLERSTEIN 999009999 0 ALEXANDER LAZZARUOLO P01775353 2126617777 3 AAL1 IAL1 2022 2023-04-26 12:10:37Z JEFFREY WALLERSTEIN 619 WEST 54TH STREET 3RD FL NEW YORK NY 10019 30718752 0 X WWW.NYSCF.ORG X 2005 NY SEE SCHEDULE O. 17 16 154 16 0 0 34249618 30384933 0 0 2574 65325 3260078 -57414 37512270 30392844 9546667 9526077 0 0 16446755 18016060 0 0 1861985 15710387 15933017 41703809 43475154 -4191539 -13082310 68785441 93436824 21284204 59027731 47501237 34409093 X SEE SCHEDULE O. 0 0 39565565 9526077 SEE SCHEDULE O. 39565565 1 1 0 0 0 0 0 0 0 0 1 0 0 1 1 1 1 0 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 0 0 1 39 0 1 154 1 0 0 0 0 0 0 0 0 0 0 0 0 X 17 16 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA NY X NEW YORK STEM CELL FOUNDATION 2123657428 619 WEST 54TH STREET 3RD FL NEW YORK NY 10019 ROY GERONEMUS CHAIRMAN & DIRECTOR 6.00 X X 0 0 0 DERRICK ROSSI DIRECTOR & ACTING CEO 10.00 X X 0 0 0 MARGO ALEXANDER TREASURER & DIRECTOR 6.00 X X 0 0 0 MARILYN BRESLOW DIRECTOR 3.00 X 0 0 0 PEGGY BRIM DIRECTOR 3.00 X 0 0 0 KAREN BURKE DIRECTOR 3.00 X 0 0 0 FRANCESCO CLARK DIRECTOR 3.00 X 0 0 0 RICHARD J MASSEY DIRECTOR 3.00 X 0 0 0 PAUL GOLDBERGER DIRECTOR 3.00 X 0 0 0 PAUL M MEISTER DIRECTOR 3.00 X 0 0 0 GEORGE LAZARUS DIRECTOR 3.00 X 0 0 0 SIDDHARTHA MUKHERJEE DIRECTOR 3.00 X 0 0 0 STEPHEN M ROSS DIRECTOR 3.00 X 0 0 0 KAY UNGER DIRECTOR 3.00 X 0 0 0 STEPHEN M SCHERR DIRECTOR 3.00 X 0 0 0 CLYDE WILLIAMS DIRECTOR 3.00 X 0 0 0 SUSAN SOLOMON CEO (THROUGH SEPT. 8, 2022) 40.00 X X 604612 0 28731 JEFFREY WALLERSTEIN CFO & COO 40.00 X 502135 0 45972 DANIEL PAULL VICE PRESIDENT, STEM CELL TECHNOLOGY PLATFORMS 40.00 X 352302 0 41214 FREDERICK MONSMA SENIOR VICE PRESIDENT, SCIENTIFIC OPERATIONS 40.00 X 296351 0 26586 CHRISTINE LIN CHIEF ADVANCEMENT OFFICER 40.00 X 288829 0 28167 SIMI AHMED SENIOR VICE PRESIDENT, STRATEGIC PARTNERSHIPS 40.00 X 283254 0 31867 SCOTT NOGGLE SENIOR VICE PRESIDENT, RESEARCH 40.00 X 275943 0 46003 2603426 0 248540 7 0 1 0 GOODWIN PROCTER LLC 100 NORTHERN AVE BOSTON MA 02210 LEGAL 1123273 1 2190411 2357417 25837105 172707 30384933 62782 62782 16012 16012 175250 172707 2543 2543 2543 64664 2190411 153201 -88537 -88537 OTHER INCOME 900099 15111 15111 15111 30392844 0 0 7911 8326077 8326077 1200000 1200000 794815 462807 232565 99443 14124431 12301276 794274 1028881 564626 493626 34781 36219 1519318 1318007 81283 120028 1012870 874959 69768 68143 932737 899282 33455 38244 881 37363 372530 215521 110265 46744 454893 359264 70764 24865 4750599 4256465 251052 243082 10080 1175 7286 1619 677238 612950 64288 463923 412982 30738 20203 2631717 2434114 119026 78577 333742 289912 27170 16660 LABORATORY EXPENSES 4795042 4795042 OTHER 196189 134366 61823 0 PRINTING & VIDEO PROD. 190722 110600 12010 68112 DUES & SUBSCRIPTIONS 69006 53892 5705 9409 16355 12367 3988 43475154 39565565 2047604 1861985 1000 1000 3301338 1230871 40474940 30341368 702150 821463 43354489 21182834 23270497 22171655 1035516 38870467 68785441 93436824 2076169 3815348 1993380 1294164 114119 81200 6494576 5143586 10605960 48693433 21284204 59027731 X 6351869 4929872 41149368 29479221 47501237 34409093 68785441 93436824 X -13082310 -5674 -4160 X X 0 1 X 1 1 1 X 36843837 20431488 41698818 34249618 30384933 163608694 36843837 20431488 41698818 34249618 30384933 163608694 52225346 111383348 3113565 1179634 354747 3071546 78794 7798286 173762 400 1536965 191106 15111 1917344 173324324 0.64260 0.54580 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 28857246 8443602 20413644 14497243 12739232 1758011 22171655 OTHER ASSETS 1269025 INTEREST RATE SWAP ASSET 124920 RIGHT-OF-USE ASSET, NET OPERATING LEASE (SEE SUPPLEMENTAL INFO IN PART XIII) 37476522 38870467 CAPITAL LEASE PAYABLE 851358 LANDLORD PAYABLE 482464 OPERATING LEASE LIABILITY (SEE PART XIII SUPPLEMENTAL) 47359611 48693433 X 30536211 -5674 213705 208031 30328180 64664 64664 30392844 43628355 153201 153201 43475154 0 43475154 PART X, LINE 2: NYSCF IS SUBJECT TO THE PROVISIONS OF THE FINANCIAL ACCOUNTING STANDARDS BOARD'S (THE "FASB") ACCOUNTING STANDARDS CODIFICATION ("ASC") TOPIC 740, INCOME TAXES, RELATING TO ACCOUNTING AND REPORTING FOR UNCERTAINTY IN INCOME TAXES. BECAUSE OF NYSCF'S GENERAL TAX-EXEMPT STATUS, THE ADOPTION OF ASC TOPIC 740-10-05 HAS NOT HAD, AND IS NOT EXPECTED TO HAVE, A MATERIAL IMPACT ON NYSCF'S FINANCIAL STATEMENTS. PART XI, LINE 2D - OTHER ADJUSTMENTS: INTEREST RATE SWAP 60,504. FUNDRAISING EXPENSES 153,201. PART XI, LINE 4B - OTHER ADJUSTMENTS: GROSS UP FUNDRAISING REVENUE 64,664. PART XII, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EXPENSES 153,201. PART IX AND X OTHER ASSETS AND LIABILITIES EFFECTIVE JULY 1, 2022, NYSCF ADOPTED THE NEW FASB ASC 842, LEASES. THE NEW STANDARD ESTABLISHES A RIGHT OF USE ("ROU") MODEL THAT REQUIRES A LESSEE TO RECORD A ROU ASSET, WHICH REPRESENTS THE RIGHT TO USE A RESPECTIVE ASSET FOR THE LEASE TERM, AND A LEASE LIABILITY ON THE STATEMENT OF FINANCIAL POSITION AT THE PRESENT VALUE OF THE REMAINING FUTURE PAYMENTS DUE UNDER THE LEASE. AS OF JUNE 30, 2023, THIS ADJUSTMENT INCREASED THE NET ROU ASSET BY $37,476,522 AND THE NET OPERATING LEASE LIABILITY BY $47,359,611. 1 EUROPE 0 0 GRANTMAKING GRANTS 900000 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES 0 0 GRANTMAKING GRANTS 300000 0 0 0 0 0 0 1200000 0 1200000 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM GRANTS 900000 WIRE 0 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES GRANT 300000 WIRE 0 4 0 0 0 0 0 0 PART I, LINE 2: NYSCF WILL CONTACT BOTH THE INDIVIDUAL AND THE INSTITUTION IN WHICH THE GRANT/FELLOWSHIP WILL BE HELD. IN ACCEPTING THE FUNDS, THE GRANTEE/FELLOW MUST AGREE TO THE TERMS AND CONDITIONS SET FORTH BY NYSCF AND ACKNOWLEDGE THAT WHILE NYSCF IS PROVIDING SUPPORT FOR THIS PROJECT, SOLE RESPONSIBILITY FOR THE SUPERVISION, DIRECTION AND CONTROL OF THE CONDUCT OF THE PROJECT LIES WITH THE GRANTEE/FELLOW. THE GRANTEE/FELLOW IS ALSO RESPONSIBLE FOR TRANSMITTING A COPY OF THE NOTIFICATION FROM NYSCF TO THEIR FACULTY SPONSOR AND HOST INSTITUTION FOR SIGNATURES. IF THE GRANT OR FELLOWSHIP IS TERMINATED PREMATURELY FOR ANY REASON OR IF THE FELLOW WISHES TO AMEND THE PROJECT, NYSCF MUST BE NOTIFIED IMMEDIATELY. PART III ACCOUNTING METHOD: GALA 2255075 2190411 64664 59427 93774 2255075 2190411 64664 59427 93774 153201 -88537 1 BOSTON CHILDREN'S HOSPITAL 300 LONGWOOD AVENUE BOSTON MA 02115 042774441 600000 0 GRANTS CALIFORNIA INSTITUTE OF TECHNOLOGY 1200 E CALIFORNIA BLVD PASADENA CA 91125 951643307 300000 0 GRANTS CINCINNATI CHILDREN'S HOSPITAL MED CTR 3333 BURNET AVE CINCINNATI OH 45229 310833936 57942 0 GRANTS COLUMBIA UNIVERSITY 615 WEST 131 STREET 6TH FL NEW YORK NY 10027 135598093 361000 0 FELLOWSHIPS CORNELL UNIVERSITY ITHACA NY 14850 ITHACA NY 14850 150532082 61000 0 FELLOWSHIPS HARVARD COLLEGE PO BOX 415649 BOSTON MA 02241 042103580 933823 0 GRANTS MASSACHUSETTS GENERAL HOSPITAL 185 CAMBRIDGE ST BOSTON MA 02114 041564655 361000 0 GRANTS MEMORIAL SLOAN-KETTERING CANCER CENTER 1275 YORK AVE NEW YORK NY 10065 131924236 361000 0 FELLOWSHIPS MONELL CHEMICAL SENSES CENTER 3500 MARKET ST PHILADELPHIA PA 19104 232020897 300000 0 GRANTS NEW YORK STEM CELL FOUNDATION 619 WEST 54TH STREET NEW YORK NY 10019 202905531 61000 0 FELLOWSHIPS NEW YORK UNIVERSITY SCHOOL OF MEDICINE 25 WEST 4TH ST ROOM 405 NEW YORK NY 10012 135562308 361000 0 GRANTS NORTHWESTERN UNIVERSITY 633 CLARK STREET EVANSTON IL 60208 362167817 300000 0 GRANTS NYU GROSSMAN SCHOOL OF MEDICINE PO BOX 415026 BOSTON MA 02241 135562309 300000 0 GRANTS PRINCETON UNIVERSITY NEW SOUTH BUILDING FOURTH FLOOR PRINCETON NJ 08545 210634501 900000 0 GRANTS STANFORD UNIVERSITY 301 RAVENSWOOD AVE MENLO PARK CA 94025 941156365 600000 0 GRANTS THE BRIGHAM AND WOMEN'S HOSPITAL 75 FRANCIS ST BOSTON MA 02115 042312909 300000 0 GRANTS UNIVERISITY OF CALIFORNIA LOS ANGELES 10920 WILSHIRE BLVD STE 620 LOS ANGELES CA 90024 956006143 300000 0 GRANTS UNIVERSITY OF CALIFORNIA SAN FRANCISCO PO BOX 748872 LOS ANGELES CA 90065 943067788 600000 0 GRANTS UNIVERSITY OF PENNSYLVANIA PHILADELPHIA PA 19104 PHILADELPHIA PA 19104 231352685 7312 0 FELLOWSHIPS UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL PO BOX 841765 DALLAS TX 75284 752556007 300000 0 GRANTS UNIVERSITY OF WASHINGTON 4333 BROOKLYN AVE NE SEATTLE WA 98195 943079432 600000 0 GRANTS YALE UNIVERSITY PO BOX 1873 NEW HAVEN CT 06508 060646973 361000 0 GRANTS 23 PART I, LINE 2: NYSCF WILL CONTACT BOTH THE INDIVIDUAL AND THE INSTITUTION IN WHICH THE GRANT/FELLOWSHIP WILL BE HELD. IN ACCEPTING THE FUNDS, THE GRANTEE/FELLOW MUST AGREE TO THE TERMS AND CONDITIONS SET FORTH BY NYSCF AND ACKNOWLEDGE THAT WHILE NYSCF IS PROVIDING SUPPORT FOR THIS PROJECT, SOLE RESPONSIBILITY FOR THE SUPERVISION, DIRECTION AND CONTROL OF THE CONDUCT OF THE PROJECT LIES WITH THE GRANTEE/FELLOW. THE GRANTEE/FELLOW IS ALSO RESPONSIBLE FOR TRANSMITTING A COPY OF THE NOTIFICATION FROM NYSCF TO THEIR FACULTY SPONSOR AND HOST INSTITUTION FOR SIGNATURES. IF THE GRANT OR FELLOWSHIP IS TERMINATED PREMATURELY FOR ANY REASON OR IF THE FELLOW WISHES TO AMEND THE PROJECT, NYSCF MUST BE NOTIFIED IMMEDIATELY. X X X X X X 0 0 0 0 0 0 0 0 0 SUSAN SOLOMON CEO (THROUGH SEPT. 8, 2022) 604612 0 0 0 0 0 15250 0 13481 0 633343 0 0 0 JEFFREY WALLERSTEIN CFO & COO 502135 0 0 0 0 0 15250 0 30722 0 548107 0 0 0 DANIEL PAULL VICE PRESIDENT, STEM CELL TECHNOLOGY 352302 0 0 0 0 0 15250 0 25964 0 393516 0 0 0 FREDERICK MONSMA SENIOR VICE PRESIDENT, SCIENTIFIC OP 296351 0 0 0 0 0 14599 0 11987 0 322937 0 0 0 SCOTT NOGGLE SENIOR VICE PRESIDENT, RESEARCH 275943 0 0 0 0 0 13506 0 32497 0 321946 0 0 0 CHRISTINE LIN CHIEF ADVANCEMENT OFFICER 288829 0 0 0 0 0 14710 0 13457 0 316996 0 0 0 SIMI AHMED SENIOR VICE PRESIDENT, STRATEGIC PAR 283254 0 0 0 0 0 5903 0 25964 0 315121 0 0 0 X 6 172707 FMV 0 1 0 PART III - LINE 4A NYSCF RESEARCH - SUPPORTING AND ENABLING THE UNRESTRICTED PURSUIT OF THE MOST ADVANCED STEM CELL RESEARCH, BOTH IN OUR OWN LABORATORY AND THROUGH COLLABORATIONS WITH MAJOR MEDICAL RESEARCH INSTITUTIONS. NYSCF FELLOWSHIP AND INNOVATOR PROGRAMS - SUPPORTING AND TRAINING THE NEXT GENERATION OF SCIENTISTS, BOTH AT THE POST-DOCTORAL LEVEL AS FELLOWS, AND AS INVESTIGATORS PURSUING INNOVATIVE WORK THAT TRANSLATES RESEARCH INTO CURES. NYSCF CONFERENCE AND SYMPOSIA - CONVENING THE PRE-EMINENT ANNUAL TRANSLATIONAL STEM CELL RESEARCH CONFERENCE AND AN ON-GOING SERIES OF PROGRAMS FOR SCIENTISTS, POLICYMAKERS AND THE PUBLIC. FORM 990, PART VI, SECTION A, LINE 2 SUSAN L. SOLOMON, CEO & DIRECTOR IS MARRIED TO PAUL GOLDBERGER, DIRECTOR JEFF WALLERSTEIN, CHIEF FINANCIAL & OPERATING OFFICER IS THE BROTHER-IN-LAW OF STEPHEN SCHERR, DIRECTOR. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS DISTRIBUTED TO THE ENTIRE BOARD OF DIRECTORS FOR THEIR REVIEW PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY IS DISTRIBUTED ANNUALLY FOR REVIEW AND SIGNATURE. FORM 990, PART VI, SECTION B, LINE 15 COMPENSATION IS DETERMINED BY REVIEWING COMPARABLE ORGANIZATIONS' FORM 990, ENGAGING AN INDEPENDENT COMPENSATION CONSULTANT TO PREPARE AN ANALYSIS AND REPORT ABOUT THE CEO AND OTHER KEY EMPLOYEE'S COMPENSATION. THESE MATERIALS ARE PRESENTED TO THE ORGANIZATION'S COMPENSATION COMMITTEE, WHICH REPORTS TO THE FULL BOARD. FORM 990, PART VI, SECTION C, LINE 19 NYSCF MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XI, LINE 9: INTEREST RATE SWAP 60,504. FUNDRAISING REVENUE ADJUSTMENT -64,664. FORM 990. PART XII, LINE 2C. THE PROCESS HAS NOT BEEN CHANGED FROM THE PRIOR YEAR. FORM 990, PART XI, RECONCILIATION OF NET ASSET, LINE 3 REVENUE LESS EXPENSE NYSCF RECOGNIZES REVENUE FROM DONOR RESTRICTED GRANTS IN THE YEAR THE GRANT IS AWARDED. IN THE FOLLOWING YEARS, AS THE PURPOSE OF THE GRANT IS ACCOMPLISHED, NET ASSETS ARE RELEASED FROM DONOR RESTRICTIONS, REDUCING NET ASSETS. THIS CREATES A TIMING DIFFERENCE BETWEEN REVENUE AND EXPENSES. IN FY23 NYSCF HAD A DEFICIT IN NET ASSETS OF $13,092,144, WHICH INCLUDES NET RELEASES OF $11,670,147 FROM DONOR RESTRICTIONS. PART I - LINE 1 AND PART III - LINE 1 THE NEW YORK STEM CELL FOUNDATION ("NYSCF") IS A NOT-FOR-PROFIT ORGANIZATION THAT WAS INCORPORATED IN THE STATE OF NEW YORK ON MAY 19, 2005. NYSCF'S MISSION IS TO ACCELERATE CURES FOR THE MAJOR DISEASES OF OUR TIME THROUGH STEM CELL RESEARCH. NYSCF PROGRAMS INCLUDE: 1) NYSCF RESEARCH - SUPPORTING AND ENABLING THE UNRESTRICTED PURSUIT OF THE MOST ADVANCED STEM CELL RESEARCH, BOTH IN OUR OWN LABORATORY AND THROUGH COLLABORATIONS WITH MAJOR MEDICAL RESEARCH INSTITUTIONS; 2) NYSCF FELLOWSHIP AND INNOVATOR PROGRAMS - SUPPORTING AND TRAINING THE NEXT GENERATION OF SCIENTISTS, BOTH AT THE POST-DOCTORAL LEVEL AS FELLOWS, AND AS INVESTIGATORS PURSUING INNOVATIVE WORK THAT TRANSLATES RESEARCH INTO CURES; 3) NYSCF CONFERENCE AND SYMPOSIA - CONVENING THE PRE-EMINENT ANNUAL TRANSLATIONAL STEM CELL RESEARCH CONFERENCE AND AN ON-GOING SERIES OF PROGRAMS FOR SCIENTISTS, POLICYMAKERS AND THE PUBLIC. CELLRAY LLC 619 WEST 54TH STREET 3RD FL NEW YORK NY 10019 833338908 RESEARCH DE NYSCF CELLRAY TECHNOLOGIES INC 619 WEST 54TH STREET 3RD FL NEW YORK NY 10019 455639489 RESEARCH DE NYSCF C 1.00000 0 CELLRAY GLOBAL INC 619 WEST 54TH STREET 3RD FL NEW YORK NY 10019 463664876 RESEARCH DE NYSCF C 1.00000 0 FOUNDATION CELL THERAPEUTICS 619 WEST 54TH STREET 3RD FL NEW YORK NY 10019 371905708 RESEARCH DE NYSCF C 1.00000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0